About Rhaeos
Rhaeos is a Technology company based in Evanston (United States) founded in 2018 by Amit Ayer, Siddharth Krishnan, and John Rogers. Noninvasive device developed for CSF monitoring and hydrocephalus management. It operates on a HealthTech model in Technology and Healthcare sectors. Rhaeos has raised $12.8 million across 9 funding rounds from investors including NIH, HHS and Northwestern University. The company has 10 employees. Its chief executive, as recorded, is Anna Lisa Somera. Rhaeos offers products and services including FlowSense. Its focus areas include Medical Devices and Neurological Devices. Its legal entity is Rhaeos, Inc. Its competitors include Ceribell, Kernel and NeuroKaire; 3 of its 3 listed competitors have raised funding.
Company details
Rhaeos is engaged in the development of non-invasive, wireless, and wearable medical devices for hydrocephalus patients. Their primary product, FlowSense, is designed to assess shunt flow in minutes, addressing challenges in detecting shunt malfunctions. The company operates within the healthcare sector, targeting solutions for neurological conditions. Collaborations with various partners and participation in clinical events are maintained to advance their investigational devices. Their technology aims to reduce readmission rates and emergency department visits for hydrocephalus patients in the United States.
- Headquarters Evanston, United States
- Employees 10
- Founders Amit Ayer, Siddharth Krishnan, John Rogers
- SectorsTechnologyHealthcare
- Website rhaeos.com
- Social LinkedIn X Instagram
- Legal Name Rhaeos, Inc.
- Total Equity Funding$12.8M (USD)
in 9 rounds
- Latest Funding Round$306.52K (USD), Grant
Sep 2024
- InvestorsNIH
& 14 more
- Employee Count10
Products & Services of Rhaeos
Rhaeos offers a comprehensive portfolio of products and services, including FlowSense.
FlowSense assesses hydrocephalus shunt flow in minutes.
Funding Insights of Rhaeos
Rhaeos has successfully raised a total of $12.8M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $306.52 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.8M
- Total Rounds 9
- Last Round Grant — $306,522
- First Round $250,000
(Jan 2020)
- Investors Count 15
All 9 funding rounds of Rhaeos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $306,522 | Grant | – | – | |
| Oct 2023 | $1.5M | Grant | – | – | |
| Feb 2023 | $10.5M | Series A | – | Artistic Ventures, Steele Foundation for Hope | |
| Dec 2021 | $2.2M | Seed | – | – | |
| Sep 2021 | $966,022 | Grant | – | – | |
| Apr 2021 | $100,000 | Seed | – | Gener8tor | – |
| Mar 2021 | $978,557 | Grant | – | – | |
| Oct 2020 | $350,000 | Grant | – | – | |
| Jan 2020 | $250,000 | Grant | – | – |
15 investors in total: 15 institutional.
Investors in Rhaeos
Rhaeos has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Northwestern University.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| artistic.vc | ||||
Venture capital fund focused on multiple sectors | lateralcapital.com | Sarasota, United States | ||
Creative Ventures is focused on deep tech venture investments. | creativeventures.vc | San Francisco Bay Area, United States | ||
Portal Innovations is engaged in funding life sciences startups. | portalinnovations.com | Chicago, United States | ||
A health-tech accelerator program is operated by Cedars-Sinai. | 2016 | csaccelerator.com | Los Angeles, United States | |
Impact VC investments are directed toward US tech startups. | umsocialventure.com | Ann Arbor, United States | ||
Angel investing in high-tech and life science startups since 1994. | bandangels.com | |||
Startups are accelerated via a 12-week program with funding support. | 2012 | gener8tor.com | Madison, United States | |
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide. | medtechinnovator.org |
Investor details for Rhaeos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rhaeos
24 people are tracked at Rhaeos (9 in leadership, 11 in board & advisors, 4 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Amit Ayer | Co-Founder | Leadership |
Siddharth Krishnan | Co-Founder | Leadership |
John Rogers | Co-Founder & President | Leadership |
Anna Lisa Somera | CEO | Leadership |
Chris Gornick | VP Of Commercial Strategy | Leadership |
John Adair | Fractional CFO | Leadership |
Adam Zysk | Chief Innovation Officer | Leadership |
Jenna Koschnitzky | Senior Director, Neurosurgery Research | Leadership |
Nikhil S. | Operations / Chief Of Staff, Office Of The CEO | Leadership |
Mitali Stevens | Market Access Lead | Board & advisors |
Joe Exner | Director | Board & advisors |
Kulika Weizman | Director | Board & advisors |
Roozbeh Ghaffari | Advisor | Board & advisors |
James Killeffer | Advisor | Board & advisors |
Keith L. Black | Advisor | Board & advisors |
Kevin Sheth | Advisor | Board & advisors |
Chad Seaver | Advisor | Board & advisors |
Robert Kline | Advisor | Board & advisors |
Kim Rodriguez | Advisor | Board & advisors |
Matthew Potts | Advisor | Board & advisors |
4 more people are available in the full profile.
Complete people profiles for Rhaeos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rhaeos
3 dated milestones of Rhaeos across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Rhaeos is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Grant, of $307K.
Competitors of Rhaeos
Rhaeos has 3 listed competitors in our database, 3 of them funded. They include Ceribell, Kernel and NeuroKaire.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ceribell.com | 2014 | Mountain View, United States | $187.52M | 218 | Portable EEG devices for point-of-care seizure diagnosis are provided. | |
| kernel.com | 2016 | Los Angeles, United States | $158.25M | Multimodal brain measurement technology is developed for neuromedicine applications. | ||
| neurokaire.com | 2017 | Kearny, United States | $20M | Platform offering personalized treatment for psychiatric and neurological conditions |
Detailed competitors of Rhaeos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rhaeos
The website of Rhaeos (rhaeos.com) receives about 3K visits a month.
- Monthly visits3K
▲ 64.1% vs previous month
Websites whose visitors overlap most with Rhaeos. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
lifesciencemarketresearch.com | lifesciencemarketresearch.com | 100% | #1,404,464 | – |
Top companies in Sensors & Smart Devices
3 companies that operate in the same segment as Rhaeos (Sensors & Smart Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
VR-based head-mounted displays for gaming are provided by Oculus. | 2012 | Menlo Park, California, United States | USD 107.05 M | |||
Cloud-based business telephony and home security services are provided. | 2004 | Palo Alto, California, United States | USD 87.97 M | USD 273.6 M | 1,190 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rhaeos
Complete news archive for Rhaeos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rhaeos
Rhaeos was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Rhaeos is headquartered in Evanston, United States. It is registered at Evanston, Illinois, United States.
Anna Lisa Somera is the CEO of Rhaeos, as recorded in our data.
Rhaeos is a funded company, having raised a total of $12.8M across 9 funding rounds to date. The company's 1st funding round was a Grant of $250K, raised on Jan 2020.
Rhaeos has 10 employees.
Rhaeos is engaged in the development of non-invasive, wireless, and wearable medical devices for hydrocephalus patients. Their primary product, FlowSense, is designed to assess shunt flow in minutes, addressing challenges in detecting shunt malfunctions. The company operates within the healthcare sector, targeting solutions for neurological conditions. Collaborations with various partners and participation in clinical events are maintained to advance their investigational devices. Their technology aims to reduce readmission rates and emergency department visits for hydrocephalus patients in the United States.
Rhaeos's top competitors include Ceribell, NeuroKaire and Kernel.
Rhaeos offers FlowSense.
Rhaeos has 15 investors. Key investors include NIH, HHS, Northwestern University, Gener8tor, and Artistic Ventures.
Rhaeos operates through Rhaeos, Inc..